Eagle Pharmaceuticals to Present at November Conferences

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)-- Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) announced today that Scott Tarriff, President and Chief Executive Officer, and David Riggs, Chief Financial Officer, will each present at two conferences in November as follows:

Each presentation will be webcast live at the aforementioned times, and archived for 90 days thereafter, via the company’s website at www.eagleus.com, under the Investors Section.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the company’s website at www.eagleus.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151112005377/en/

In-Site Communications, Inc.
Lisa M. Wilson, 212-452-2793
President

Source: Eagle Pharmaceuticals, Inc.

You May Also Be Interested In

• Jefferies cuts Apple rating as higher-priced iPhone roadmap looks difficult
• Armenian Lacrosse Daily Bible Readings Road Trip Across Armenia: 11 August to 22 August 2026
• Notation Labs Introduces LeakSecure® Platform 3.0, Turning Real-Time Water Data into Coordinated Action